Bladder cancer
Alerts and Notices
Synopsis
Risk factors for development of bladder carcinoma include advancing age, male sex, being of Northern European descent, and cigarette smoking. Occupations with exposures linked to increased risk of bladder cancer include metal workers, painters, leather workers, miners, excavating-machine operators, and manufacturers of carpets, paints, plastics, and industrial chemicals.
Patients with bladder cancer typically present with painless gross or microscopic hematuria, although dysuria, frequency, and urgency may be the presenting symptoms. Diagnosis may be delayed due to the similarity of these symptoms to benign conditions such as urinary tract infections, nephrolithiasis, cystitis, or prostatitis. Urothelial cancer may mimic bladder cancer. In patients younger than 50 years, asymptomatic microscopic hematuria is rarely associated with bladder cancer.
Treatment options depend on depth of tumor invasion and presence or absence of metastatic disease. Transurethral resection of bladder tumor (TURBT) may be combined with adjuvant chemotherapy for early-stage disease with radical cystectomy and/or chemotherapy in late-stage disease.
Codes
ICD10CM:C67.9 – Malignant neoplasm of bladder, unspecified
SNOMEDCT:
399326009 – Malignant tumor of urinary bladder
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.Subscription Required
References
Subscription Required
Last Reviewed:03/29/2018
Last Updated:10/21/2020
Last Updated:10/21/2020
Bladder cancer